Related Experiment Video
Updated: Dec 31, 2025

Reconstruct Human Retinoblastoma In Vitro
Published on: October 11, 2022
Retinoblastoma Presentation and Survival: A four-year analysis from a tertiary care hospital
Nida Zia1, Ahmer Hamid2, Sundus Iftikhar3
1Nida Zia, MCPS. Department of Peads Oncology, The Indus Hospital, Karachi, Pakistan.
Insights
This study on Retinoblastoma (Rb) in Pakistan found that delayed presentation and advanced disease significantly impact outcomes. Early recognition of warning signs is crucial for improving survival rates in pediatric cancer patients.
Area of Science:
- Pediatric Oncology
- Ophthalmology
- Cancer Research
Background:
- Retinoblastoma (Rb) is a common childhood eye cancer.
- Understanding clinical presentation and treatment outcomes is vital for improving patient survival.
Purpose of the Study:
- To analyze the clinical characteristics, treatment modalities, and outcomes of Retinoblastoma patients.
- To identify factors influencing the progression and survival of pediatric Rb in Pakistan.
Main Methods:
- Retrospective analysis of 93 Retinoblastoma patients treated at The Indus Hospital, Karachi (2013-2017).
- Data collected included demographics, symptoms, tumor laterality and extent, treatment type, relapse, and survival.
- Outcomes were evaluated based on disease progression and patient survival.
Main Results:
- Leukocoria (61.3%) and proptosis (37.6%) were the most frequent symptoms.
- Advanced disease at presentation was common: 43.5% extraocular tumors and 28.1% metastasis.
- Treatments included enucleation (46.2%), chemotherapy (80.6%), and radiation therapy (29.3%).
Conclusions:
- Delayed presentation, recurrent disease, and metastasis negatively impacted outcomes.
- Increased awareness of early warning signs among the public and healthcare professionals is essential.
- Timely diagnosis and management are critical to reduce Retinoblastoma morbidity and mortality.
Objective:
To study the clinical presentation, treatment, and outcome of Retinoblastoma (Rb) in a tertiary care hospital of Pakistan.
Methods:
A retrospective study was conducted in the Department of Pediatric Hematology Oncology, The Indus Hospital (TIH), Karachi from 1st June 2013 to 30th June 2017. Data including patients' demography, clinical symptoms and duration, laterality, extent of the tumor, type of treatment, relapse, and final outcome were extracted and evaluated with respect to progression and survival.
Results:
A total of 93 patients were included; 34.4% were boys. The median age at presentation was 30 months. Leukocoria was the commonest symptom (61.3%), followed by proptosis (37.6%). Unilateral disease was seen in 59.1%, extraocular tumors in 43.5% and metastasis in 28.1%. Enucleation was performed on 46.2%, chemotherapy given to 80.6% and external beam radiation therapy to 29.3% patients.
Conclusion:
Delayed presentation, recurrent disease, extraocular disease and metastasis on presentation were factors affecting outcome in our cohort. Awareness about the early warning signs and symptoms in both public and health professionals for early recognition and timely management are mandatory to decrease morbidity and mortality.
More Related Videos
07:55Establishment and Propagation of Human Retinoblastoma Tumors in Immune Deficient Mice
Published on: August 4, 2011
11:09Establishing Intracranial Brain Tumor Xenografts With Subsequent Analysis of Tumor Growth and Response to Therapy using Bioluminescence Imaging
Published on: July 13, 2010
Related Concept Videos
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Cancer Survival Analysis
Actuarial Approach
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Introduction To Survival Analysis
The primary goal of survival analysis is to estimate survival time—the time...